Target
5-hydroxytryptamine receptor 2A
Ligand
BDBM50081701
Substrate
n/a
Meas. Tech.
Radioligand Binding Assay
IC50
<500±n/a nM
Citation
 Slassi, AAraujo, J 3-pyrrolidine-indole derivatives as serotonergic psychedelic agents for the treatment of CNS disorders US Patent  US11453689 Publication Date 9/27/2022 
Target
Name:
5-hydroxytryptamine receptor 2A
Synonyms:
5-HT-2 | 5-HT-2A | 5-HT2A | 5-hydroxytryptamine receptor 2A (5-HT-2A) | 5-hydroxytryptamine receptor 2A (5HT-2A) | 5-hydroxytryptamine receptor 2A (5HT2A) | 5HT2A_HUMAN | HTR2 | HTR2A | Serotonin receptor 2A
Type:
undefined
Mol. Mass.:
52607.65
Organism:
Homo sapiens (Human)
Description:
P28223
Residue:
471
Sequence:
MDILCEENTSLSSTTNSLMQLNDDTRLYSNDFNSGEANTSDAFNWTVDSENRTNLSCEGCLSPSCLSLLHLQEKNWSALLTAVVIILTIAGNILVIMAVSLEKKLQNATNYFLMSLAIADMLLGFLVMPVSMLTILYGYRWPLPSKLCAVWIYLDVLFSTASIMHLCAISLDRYVAIQNPIHHSRFNSRTKAFLKIIAVWTISVGISMPIPVFGLQDDSKVFKEGSCLLADDNFVLIGSFVSFFIPLTIMVITYFLTIKSLQKEATLCVSDLGTRAKLASFSFLPQSSLSSEKLFQRSIHREPGSYTGRRTMQSISNEQKACKVLGIVFFLFVVMWCPFFITNIMAVICKESCNEDVIGALLNVFVWIGYLSSAVNPLVYTLFNKTYRSAFSRYIQCQYKENKKPLQLILVNTIPALAYKSSQLQMGQKKNSKQDAKTTDNDCSMVALGKQHSEEASKDNSDGVNEKVSCV
  
Inhibitor
Name:
BDBM50081701
Synonyms:
3-[2-(dimethylamino)ethyl]-1H-indol-4-ol | 4-hydroxy-N,N-dimethyltryptamine | CHEMBL65547 | N,N-dimethyl-4-hydroxytryptamine | Psilocin | US11427604, Compound (I-45) | US11453689, Compound Psilocin | US11591353, Compound I-45 | US11597738, Example 3 | US11642336, Compound Psilocin | US20240051978, Compound Psilocin
Type:
Small organic molecule
Emp. Form.:
C12H16N2O
Mol. Mass.:
204.2682
SMILES:
CN(C)CCc1c[nH]c2cccc(O)c12
Structure:
Search PDB for entries with ligand similarity: